As of 2025-06-19, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (0.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.00 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -148.9%.
The range of the Relative Valuation is (0.82) - (1.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 24.4x | 21.7x |
| Forward P/E multiples | 14.3x - 23.9x | 16.6x |
| Fair Price | (0.82) - (1.22) | (0.98) |
| Upside | -141.0% - -161.0% | -148.9% |
| Date | P/E |
| 2025-06-09 | -41.54 |
| 2025-06-06 | -41.15 |
| 2025-06-05 | -39.19 |
| 2025-06-04 | -39.98 |
| 2025-06-03 | -39.19 |
| 2025-06-02 | -37.82 |
| 2025-05-30 | -36.84 |
| 2025-05-29 | -37.43 |
| 2025-05-28 | -35.86 |
| 2025-05-27 | -37.04 |
| 2025-05-23 | -36.25 |
| 2025-05-22 | -36.65 |
| 2025-05-21 | -36.84 |
| 2025-05-20 | -37.63 |
| 2025-05-19 | -37.63 |
| 2025-05-16 | -38.61 |
| 2025-05-15 | -36.65 |
| 2025-05-14 | -33.71 |
| 2025-05-13 | -36.06 |
| 2025-05-12 | -40.17 |
| 2025-05-09 | -41.35 |
| 2025-05-08 | -42.52 |
| 2025-05-07 | -44.29 |
| 2025-05-06 | -47.42 |
| 2025-05-05 | -41.74 |
| 2025-05-02 | -45.27 |
| 2025-05-01 | -46.05 |
| 2025-04-30 | -47.42 |
| 2025-04-29 | -45.86 |
| 2025-04-28 | -45.66 |
| 2025-04-25 | -45.07 |
| 2025-04-24 | -44.48 |
| 2025-04-23 | -43.11 |
| 2025-04-22 | -42.13 |
| 2025-04-21 | -37.82 |
| 2025-04-17 | -36.06 |
| 2025-04-16 | -36.06 |
| 2025-04-15 | -37.63 |
| 2025-04-14 | -37.82 |
| 2025-04-11 | -37.43 |
| 2025-04-10 | -35.67 |
| 2025-04-09 | -36.84 |
| 2025-04-08 | -34.69 |
| 2025-04-07 | -38.41 |
| 2025-04-04 | -41.15 |
| 2025-04-03 | -41.94 |
| 2025-04-02 | -43.70 |
| 2025-04-01 | -41.35 |
| 2025-03-31 | -43.11 |
| 2025-03-28 | -44.29 |